Short answer
ASP Isotopes Inc. (ASPI) filed an 8-K current report with the SEC on July 30, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item 7.01 (Regulation FD Disclosure). ASP Isotopes to participate in Canaccord Genuity’s 46th Annual Growth Conference on August 12, 2026.
ASP Isotopes Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- ASP Isotopes to participate in Canaccord Genuity’s 46th Annual Growth Conference on August 12, 2026
- Investor relevance: potential opportunity for management commentary and updated business outlook during the conference
Item EX-99.1 · Exhibit EX-99.1
- Management presentation scheduled for August 12, 2026, at 8:00 a.m. ET at Canaccord Genuity’s 46th Annual Growth Conference
- Investor webcast may provide updates on isotope-enrichment commercialization, facilities, funding needs, or strategic plans
- Proposed ENDRA merger remains subject to SEC filings, stockholder approval, regulatory conditions, and closing risks
- Company highlights commercialization risks for ASP and QE technologies, plant commissioning, regulatory approvals, and future funding needs
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ASP Isotopes Inc. 8-K filings
Get the next ASPI 8-K as it lands
Follow ASPI for push alerts, or ask the research agent what this filing means.